165 related articles for article (PubMed ID: 17151306)
1. Treatment of diabetic polyneuropathy: Update 2006.
Ziegler D
Ann N Y Acad Sci; 2006 Nov; 1084():250-66. PubMed ID: 17151306
[TBL] [Abstract][Full Text] [Related]
2. Pathogenetic treatments for diabetic peripheral neuropathy.
Ziegler D
Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110764. PubMed ID: 38245327
[TBL] [Abstract][Full Text] [Related]
3. Diabetic Neuropathies.
Elafros MA; Callaghan BC
Continuum (Minneap Minn); 2023 Oct; 29(5):1401-1417. PubMed ID: 37851036
[TBL] [Abstract][Full Text] [Related]
4. Review of Diabetic Polyneuropathy: Pathogenesis, Diagnosis and Management According to the Consensus of Egyptian Experts.
Amara F; Hafez S; Orabi A; El Etriby A; Abdel Rahim AA; Zakaria E; Koura F; Talaat FM; Gawish H; Attia I; Abdel Aziz MF; El Hefnawy MHMF; Kamar M; Halawa MR; El-Sayed MS; El Kafrawy NA; Khalil SHA; Assaad SN
Curr Diabetes Rev; 2019; 15(4):340-345. PubMed ID: 30813879
[TBL] [Abstract][Full Text] [Related]
5. Polyneuropathy is inadequately treated despite increasing symptom intensity in individuals with and without diabetes (PROTECT follow-up study).
Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A
J Diabetes Investig; 2020 Sep; 11(5):1272-1277. PubMed ID: 32268450
[TBL] [Abstract][Full Text] [Related]
6. Update on the management of diabetic polyneuropathies.
Shakher J; Stevens MJ
Diabetes Metab Syndr Obes; 2011; 4():289-305. PubMed ID: 21887102
[TBL] [Abstract][Full Text] [Related]
7. Diabetic neuropathy part 2: proximal and asymmetric phenotypes.
Pasnoor M; Dimachkie MM; Barohn RJ
Neurol Clin; 2013 May; 31(2):447-62. PubMed ID: 23642718
[TBL] [Abstract][Full Text] [Related]
8. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes.
Albers JW; Pop-Busui R
Curr Neurol Neurosci Rep; 2014 Aug; 14(8):473. PubMed ID: 24954624
[TBL] [Abstract][Full Text] [Related]
9. Advances in diagnosis and management of distal sensory polyneuropathies.
Silsby M; Feldman EL; Dortch RD; Roth A; Haroutounian S; Rajabally YA; Vucic S; Shy ME; Oaklander AL; Simon NG
J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):1025-1039. PubMed ID: 36997315
[TBL] [Abstract][Full Text] [Related]
10. Alpha-lipoic acid for diabetic peripheral neuropathy.
Baicus C; Purcarea A; von Elm E; Delcea C; Furtunescu FL
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012967. PubMed ID: 38205823
[TBL] [Abstract][Full Text] [Related]
11. Brain-Computer Interface to Deliver Individualized Multisensory Intervention for Neuropathic Pain.
Aurucci GV; Preatoni G; Damiani A; Raspopovic S
Neurotherapeutics; 2023 Sep; 20(5):1316-1329. PubMed ID: 37407726
[TBL] [Abstract][Full Text] [Related]
12. Effect of Alpha-Lipoic Acid in the Treatment of Diabetic Neuropathy: A Systematic Review.
Abubaker SA; Alonazy AM; Abdulrahman A
Cureus; 2022 Jun; 14(6):e25750. PubMed ID: 35812639
[TBL] [Abstract][Full Text] [Related]
13. Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration.
Islam MR; Nyholt DR
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627115
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Review of Neuronal Changes in Diabetics.
Luna R; Talanki Manjunatha R; Bollu B; Jhaveri S; Avanthika C; Reddy N; Saha T; Gandhi F
Cureus; 2021 Oct; 13(10):e19142. PubMed ID: 34868777
[TBL] [Abstract][Full Text] [Related]
15. Effects of Upregulation of TNFAIP3 on Diabetic Neuropathic Pain in Mice.
Liu Y; Li J; Yao H; Zhang M; Lian J; Zhang H; Zhang K; Liu D; Chen J; Wang Y; Gao Y
Dis Markers; 2021; 2021():3470950. PubMed ID: 34853620
[TBL] [Abstract][Full Text] [Related]
16.
Su C; Schwarz TL
J Neurosci; 2017 Feb; 37(8):2125-2136. PubMed ID: 28115479
[No Abstract] [Full Text] [Related]
17. [Diabetic neuropathy].
Lechleitner M; Abrahamian H; Francesconi C; Kofler M
Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S73-9. PubMed ID: 27052228
[TBL] [Abstract][Full Text] [Related]
18. Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.
Huang L; He R; Luo W; Zhu YS; Li J; Tan T; Zhang X; Hu Z; Luo D
Recent Pat Anticancer Drug Discov; 2016; 11(2):184-96. PubMed ID: 26844556
[TBL] [Abstract][Full Text] [Related]
19. Antineuropathic effect of 7-hydroxy-3,4-dihydrocadalin in streptozotocin-induced diabetic rodents.
Rocha-González HI; Ramírez-Aguilar M; Granados-Soto V; Reyes-García JG; Torres-López JE; Huerta-Cruz JC; Navarrete A
BMC Complement Altern Med; 2014 Apr; 14():129. PubMed ID: 24708659
[TBL] [Abstract][Full Text] [Related]
20. Electrical stimulation as an adjunctive treatment of painful and sensory diabetic neuropathy.
Thakral G; Kim PJ; LaFontaine J; Menzies R; Najafi B; Lavery LA
J Diabetes Sci Technol; 2013 Sep; 7(5):1202-9. PubMed ID: 24124947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
